Atossa Therapeutics Inc (ATOS)

01:30 AM

Does Atossa Therapeutics Inc. stock pay reliable dividendsFree Consultation - jammulinksnews.com

01:30 AM

12:27 PM

Will Atossa Therapeutics Inc. stock split in the near futureDynamic investment growth - jammulinksnews.com

12:27 PM

Jul 23, 2025

What drives Atossa Therapeutics Inc. stock priceExceptional profit potential - Autocar Professional

Jul 23, 2025

Jul 23, 2025

Is Atossa Therapeutics Inc. a good long term investmentRapid wealth creation - jammulinksnews.com

Jul 23, 2025

Jul 22, 2025

What analysts say about Atossa Therapeutics Inc. stockTremendous wealth creation - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Atossa Therapeutics Inc. Stock Analysis and ForecastSuperior returns - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Why Atossa Therapeutics Inc. stock attracts strong analyst attentionHigh Potential Safe Trades - Newser

Jul 22, 2025

Jul 18, 2025

Should I buy Atossa Therapeutics Inc. stock before earningsHigh Win Rate Stock Ideas - Newser

Jul 18, 2025

Jul 15, 2025

How Atossa Therapeutics Inc. stock performs during market volatilityDaily Gain Forecast - Newser

Jul 15, 2025

Jul 15, 2025

What makes Atossa Therapeutics Inc. stock price move sharplyTrade With Low Risk Exposure - Newser

Jul 15, 2025

Jul 07, 2025

Ascendiant Lifts Atossa Therapeutics, Inc. (ATOS) Target Citing Strong Liquidity - MSN

Jul 07, 2025

Jun 26, 2025

15 Best Growth Stocks to Invest in for the Next 5 Years - Insider Monkey

Jun 26, 2025

Jun 15, 2025

Millennium Management LLC Purchases Shares of 29,149 Atossa Therapeutics, Inc. (NASDAQ:ATOS) - Defense World

Jun 15, 2025

Jun 09, 2025

Atossa Therapeutics, Inc. (NASDAQ:ATOS) Shares Purchased by Two Sigma Advisers LP - Defense World

Jun 09, 2025

Jun 07, 2025

Ascendiant Capital Markets Issues Positive Forecast for Atossa Therapeutics (NASDAQ:ATOS) Stock Price - Defense World

Jun 07, 2025

Jun 07, 2025

Craig Hallum Upgrades Atossa Therapeutics (NASDAQ:ATOS) to “Strong-Buy” - Defense World

Jun 07, 2025

Jun 06, 2025

Atossa Therapeutics (ATOS): Ascendiant Capital Raises Price Targ - GuruFocus

Jun 06, 2025

Jun 06, 2025

Ascendiant Capital raises Atossa Genetics stock price target to $7.50 By Investing.com - Investing.com India

Jun 06, 2025

Jun 06, 2025

Ascendiant Capital raises Atossa Genetics stock price target to $7.50 - Investing.com

Jun 06, 2025

Jun 06, 2025

Craig-Hallum Initiates Coverage of Atossa Therapeutics (BMV:ATOS) with Buy Recommendation - Nasdaq

Jun 06, 2025

Jun 05, 2025

Craig-Hallum Initiates Coverage of Atossa Therapeutics (ATOS) with Buy Recommendation - Nasdaq

Jun 05, 2025

Jun 05, 2025

This Excelerate Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga

Jun 05, 2025

Jun 05, 2025

Craig-Hallum Initiates Coverage on Atossa Therapeutics (ATOS) with Buy Rating | ATOS Stock News - GuruFocus

Jun 05, 2025

Jun 05, 2025

Atossa Therapeutics at Jefferies Conference: Strategic Moves in Breast Cancer - Investing.com Canada

Jun 05, 2025

Jun 05, 2025

Craig-Hallum initiates Atossa Genetics stock with buy rating By Investing.com - Investing.com UK

Jun 05, 2025

Jun 05, 2025

Atossa Therapeutics (ATOS) Receives Buy Rating with Promising Ca - GuruFocus

Jun 05, 2025

Jun 05, 2025

Atossa Therapeutics (ATOS) Receives Buy Rating with Promising Cancer Drug Potential | ATOS Stock News - GuruFocus

Jun 05, 2025

Jun 05, 2025

Craig Hallum Initiates Coverage on Atossa Therapeutics With Buy Rating, $4 Price Target - MarketScreener

Jun 05, 2025

Jun 05, 2025

Atossa Therapeutics (ATOS) Receives Positive Coverage and Price Target | ATOS Stock News - GuruFocus

Jun 05, 2025

Jun 02, 2025

Atossa Therapeutics to Present at the Jefferies Global Healthcare Conference - Bluefield Daily Telegraph

Jun 02, 2025

Jun 02, 2025

Atossa Therapeutics to Present at the Jefferies Global Healthcare Conference | ATOS Stock News - GuruFocus

Jun 02, 2025